Senores Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
1,091.35
-19 (-1.71%)
BSENSE

Nov 20

BSE+NSE Vol: 2.5 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
46.05
46.05
30.51
9.81
8.74
Share Warrants & Outstandings
Total Reserve
887.26
740.14
173.76
35.68
27.85
Shareholder's Funds
933.60
786.19
204.27
45.50
36.59
Minority Interest
30.94
26.06
27.44
0.00
0.00
Long-Term Borrowings
194.89
162.46
133.65
29.73
12.22
Secured Loans
111.41
80.85
27.95
0.00
0.00
Unsecured Loans
83.48
81.61
105.70
29.73
12.22
Deferred Tax Assets / Liabilities
0.59
-18.67
-14.96
2.10
-0.45
Other Long Term Liabilities
13.18
8.2
7.78
1.58
0.41
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
6.61
3.26
1.24
0.26
0.05
Total Non-Current Liabilities
215.27
155.25
127.71
33.67
12.23
Current Liabilities
Trade Payables
234.72
67.22
113.01
13.58
7.14
Other Current Liabilities
54.37
29.11
18.38
7.19
0.75
Short Term Borrowings
132.20
142.30
114.73
31.03
1.99
Short Term Provisions
2.71
2.06
1.38
0.08
0.01
Total Current Liabilities
424.00
240.69
247.50
51.88
9.88
Total Liabilities
1,603.81
1,208.19
606.92
131.05
58.70
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
542.75
318.79
238.34
28.17
7.60
Less: Accumulated Depreciation
58.04
27.46
12.05
2.62
1.15
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
484.71
291.33
226.29
25.55
6.45
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
17.46
44.17
17.77
8.05
0.35
Intangible assets under development
232.00
128.33
79.32
26.41
7.72
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
28.89
0.01
0.01
16.45
15.40
Long Term Loans & Advances
6.87
8.67
23.48
1.16
1.14
Other Non Current Assets
7.57
3.89
0.00
0.40
0.14
Total Non-Current Assets
791.38
485.76
356.01
79.72
31.65
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
89.29
56.63
37.37
3.12
2.98
Sundry Debtors
324.82
123.88
112.01
22.11
19.63
Cash and Bank
159.61
385.50
13.06
0.10
3.21
Other Current Assets
188.11
124.13
69.09
17.47
0.01
Short Term Loans and Advances
50.60
32.29
19.38
8.53
1.21
Total Current Assets
812.43
722.43
250.91
51.34
27.05
Net Current Assets (Including Current Investments)
388.43
481.74
3.41
-0.55
17.17
Total Current Assets Excluding Current Investments
812.43
722.43
250.91
51.34
27.05
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Total Assets
1,603.81
1,208.19
606.92
131.05
58.70
Contingent Liabilities
24.43
20.93
22.97
8.35
0.00
Total Debt
327.09
304.76
248.38
60.76
14.21
Book Value per share (adjusted)
202.67
170.73
66.95
46.36
41.86
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 7.33% vs 22.70% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 60.73% vs 5.40% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 49.68% vs 37.47% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 2,88,800.00% vs 0.00% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 12.46% vs 187.92% in Mar 2025

Compare Balance Sheet Results of Senores Pharma.
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
46.05
109.58
-63.53
-57.98%
Share Warrants & Outstandings
Total Reserve
887.26
1,136.85
-249.59
-21.95%
Shareholder's Funds
933.60
1,246.44
-312.84
-25.10%
Minority Interest
30.94
0.65
30.29
4,660.00%
Long-Term Borrowings
194.89
133.60
61.29
45.88%
Secured Loans
111.41
4.49
106.92
2,381.29%
Unsecured Loans
83.48
129.11
-45.63
-35.34%
Deferred Tax Assets / Liabilities
0.59
16.46
-15.87
-96.42%
Other Long Term Liabilities
13.18
7.43
5.75
77.39%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
6.61
41.24
-34.63
-83.97%
Total Non-Current Liabilities
215.27
198.73
16.54
8.32%
Current Liabilities
Trade Payables
234.72
317.24
-82.52
-26.01%
Other Current Liabilities
54.37
82.34
-27.97
-33.97%
Short Term Borrowings
132.20
61.09
71.11
116.40%
Short Term Provisions
2.71
29.64
-26.93
-90.86%
Total Current Liabilities
424.00
490.30
-66.30
-13.52%
Total Liabilities
1,603.81
1,936.12
-332.31
-17.16%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
542.75
765.53
-222.78
-29.10%
Less: Accumulated Depreciation
58.04
265.41
-207.37
-78.13%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
484.71
500.12
-15.41
-3.08%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
17.46
21.55
-4.09
-18.98%
Intangible assets under development
232.00
0.00
232.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
28.89
101.29
-72.40
-71.48%
Long Term Loans & Advances
6.87
136.39
-129.52
-94.96%
Other Non Current Assets
7.57
0.27
7.30
2,703.70%
Total Non-Current Assets
791.38
772.51
18.87
2.44%
Current Assets Loans & Advances
Current Investments
0.00
22.87
-22.87
-100.00%
Inventories
89.29
271.83
-182.54
-67.15%
Sundry Debtors
324.82
333.14
-8.32
-2.50%
Cash and Bank
159.61
68.83
90.78
131.89%
Other Current Assets
188.11
105.58
82.53
78.17%
Short Term Loans and Advances
50.60
361.38
-310.78
-86.00%
Total Current Assets
812.43
1,163.61
-351.18
-30.18%
Net Current Assets (Including Current Investments)
388.43
673.31
-284.88
-42.31%
Total Current Assets Excluding Current Investments
812.43
1,140.74
-328.31
-28.78%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,603.81
1,936.12
-332.31
-17.16%
Contingent Liabilities
24.43
335.90
-311.47
-92.73%
Total Debt
327.09
194.69
132.40
68.01%
Book Value per share (adjusted)
202.67
22.75
179.92
790.86%
Annual - Borrowings
Borrowings 327.09 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.33% vs 22.70% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 13.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 60.73% vs 5.40% in Mar 2025

Annual - Fixed Assets
Fixed Assets 502.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.68% vs 37.47% in Mar 2025

Annual - Investments
Investments 28.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2,88,800.00% vs 0.00% in Mar 2025

Annual - Current Assets
Current Assets 812.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.46% vs 187.92% in Mar 2025